世界の周期性四肢麻痺治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Periodic Paralysis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4683 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、周期性四肢麻痺治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ベータ遮断薬、炭酸脱水酵素阻害薬、その他）、用途別市場規模（低カリウム血症性周期性四肢麻痺、高カリウム血症性周期性四肢麻痺、甲状腺毒性周期性四肢麻痺、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・周期性四肢麻痺治療の市場動向 ・企業の競争状況、市場シェア ・周期性四肢麻痺治療の種類別市場規模と予測2016-2027（ベータ遮断薬、炭酸脱水酵素阻害薬、その他） ・周期性四肢麻痺治療の用途別市場規模と予測2016-2027（低カリウム血症性周期性四肢麻痺、高カリウム血症性周期性四肢麻痺、甲状腺毒性周期性四肢麻痺、その他） ・周期性四肢麻痺治療の北米市場規模2016-2027（アメリカ、カナダ） ・周期性四肢麻痺治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・周期性四肢麻痺治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・周期性四肢麻痺治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・周期性四肢麻痺治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Strongbridge Biopharma、Sun Pharmaceutical Industries Ltd、Mylan N.V.、Cadila Healthcare、Alembic Pharmaceuticals、Teva Pharmaceutical Industries Ltd、X-GEN Pharmaceuticals, Inc） ・結論

Market Analysis and Insights: Global Periodic Paralysis Treatment Market
The global Periodic Paralysis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Periodic Paralysis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Periodic Paralysis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Periodic Paralysis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Periodic Paralysis Treatment market.

Global Periodic Paralysis Treatment Scope and Market Size
Periodic Paralysis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Periodic Paralysis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Beta-Blockers
Carbonic Anhydrase Inhibitor
Others

Segment by Application
Hypokalemic Periodic Paralysis
Hyperkalemic Periodic Paralysis
Thyrotoxic Periodic Paralysis
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Strongbridge Biopharma
Sun Pharmaceutical Industries Ltd
Mylan N.V.
Cadila Healthcare
Alembic Pharmaceuticals
Teva Pharmaceutical Industries Ltd
X-GEN Pharmaceuticals, Inc

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Periodic Paralysis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Beta-Blockers
1.2.3 Carbonic Anhydrase Inhibitor
1.2.4 Others
1.3 Market by Application
1.3.1 Global Periodic Paralysis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hypokalemic Periodic Paralysis
1.3.3 Hyperkalemic Periodic Paralysis
1.3.4 Thyrotoxic Periodic Paralysis
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Periodic Paralysis Treatment Market Perspective (2016-2027)
2.2 Periodic Paralysis Treatment Growth Trends by Regions
2.2.1 Periodic Paralysis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Periodic Paralysis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Periodic Paralysis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Periodic Paralysis Treatment Industry Dynamic
2.3.1 Periodic Paralysis Treatment Market Trends
2.3.2 Periodic Paralysis Treatment Market Drivers
2.3.3 Periodic Paralysis Treatment Market Challenges
2.3.4 Periodic Paralysis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Periodic Paralysis Treatment Players by Revenue
3.1.1 Global Top Periodic Paralysis Treatment Players by Revenue (2016-2021)
3.1.2 Global Periodic Paralysis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Periodic Paralysis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Periodic Paralysis Treatment Revenue
3.4 Global Periodic Paralysis Treatment Market Concentration Ratio
3.4.1 Global Periodic Paralysis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Periodic Paralysis Treatment Revenue in 2020
3.5 Periodic Paralysis Treatment Key Players Head office and Area Served
3.6 Key Players Periodic Paralysis Treatment Product Solution and Service
3.7 Date of Enter into Periodic Paralysis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Periodic Paralysis Treatment Breakdown Data by Type
4.1 Global Periodic Paralysis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Periodic Paralysis Treatment Forecasted Market Size by Type (2022-2027)

5 Periodic Paralysis Treatment Breakdown Data by Application
5.1 Global Periodic Paralysis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Periodic Paralysis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Periodic Paralysis Treatment Market Size (2016-2027)
6.2 North America Periodic Paralysis Treatment Market Size by Type
6.2.1 North America Periodic Paralysis Treatment Market Size by Type (2016-2021)
6.2.2 North America Periodic Paralysis Treatment Market Size by Type (2022-2027)
6.2.3 North America Periodic Paralysis Treatment Market Size by Type (2016-2027)
6.3 North America Periodic Paralysis Treatment Market Size by Application
6.3.1 North America Periodic Paralysis Treatment Market Size by Application (2016-2021)
6.3.2 North America Periodic Paralysis Treatment Market Size by Application (2022-2027)
6.3.3 North America Periodic Paralysis Treatment Market Size by Application (2016-2027)
6.4 North America Periodic Paralysis Treatment Market Size by Country
6.4.1 North America Periodic Paralysis Treatment Market Size by Country (2016-2021)
6.4.2 North America Periodic Paralysis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Periodic Paralysis Treatment Market Size (2016-2027)
7.2 Europe Periodic Paralysis Treatment Market Size by Type
7.2.1 Europe Periodic Paralysis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Periodic Paralysis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Periodic Paralysis Treatment Market Size by Type (2016-2027)
7.3 Europe Periodic Paralysis Treatment Market Size by Application
7.3.1 Europe Periodic Paralysis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Periodic Paralysis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Periodic Paralysis Treatment Market Size by Application (2016-2027)
7.4 Europe Periodic Paralysis Treatment Market Size by Country
7.4.1 Europe Periodic Paralysis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Periodic Paralysis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Periodic Paralysis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Periodic Paralysis Treatment Market Size by Type
8.2.1 Asia-Pacific Periodic Paralysis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Periodic Paralysis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Periodic Paralysis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Periodic Paralysis Treatment Market Size by Application
8.3.1 Asia-Pacific Periodic Paralysis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Periodic Paralysis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Periodic Paralysis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Periodic Paralysis Treatment Market Size by Region
8.4.1 Asia-Pacific Periodic Paralysis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Periodic Paralysis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Periodic Paralysis Treatment Market Size (2016-2027)
9.2 Latin America Periodic Paralysis Treatment Market Size by Type
9.2.1 Latin America Periodic Paralysis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Periodic Paralysis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Periodic Paralysis Treatment Market Size by Type (2016-2027)
9.3 Latin America Periodic Paralysis Treatment Market Size by Application
9.3.1 Latin America Periodic Paralysis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Periodic Paralysis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Periodic Paralysis Treatment Market Size by Application (2016-2027)
9.4 Latin America Periodic Paralysis Treatment Market Size by Country
9.4.1 Latin America Periodic Paralysis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Periodic Paralysis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Periodic Paralysis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Periodic Paralysis Treatment Market Size by Type
10.2.1 Middle East & Africa Periodic Paralysis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Periodic Paralysis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Periodic Paralysis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Periodic Paralysis Treatment Market Size by Application
10.3.1 Middle East & Africa Periodic Paralysis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Periodic Paralysis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Periodic Paralysis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Periodic Paralysis Treatment Market Size by Country
10.4.1 Middle East & Africa Periodic Paralysis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Periodic Paralysis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Strongbridge Biopharma
11.1.1 Strongbridge Biopharma Company Details
11.1.2 Strongbridge Biopharma Business Overview
11.1.3 Strongbridge Biopharma Periodic Paralysis Treatment Introduction
11.1.4 Strongbridge Biopharma Revenue in Periodic Paralysis Treatment Business (2016-2021)
11.1.5 Strongbridge Biopharma Recent Development
11.2 Sun Pharmaceutical Industries Ltd
11.2.1 Sun Pharmaceutical Industries Ltd Company Details
11.2.2 Sun Pharmaceutical Industries Ltd Business Overview
11.2.3 Sun Pharmaceutical Industries Ltd Periodic Paralysis Treatment Introduction
11.2.4 Sun Pharmaceutical Industries Ltd Revenue in Periodic Paralysis Treatment Business (2016-2021)
11.2.5 Sun Pharmaceutical Industries Ltd Recent Development
11.3 Mylan N.V.
11.3.1 Mylan N.V. Company Details
11.3.2 Mylan N.V. Business Overview
11.3.3 Mylan N.V. Periodic Paralysis Treatment Introduction
11.3.4 Mylan N.V. Revenue in Periodic Paralysis Treatment Business (2016-2021)
11.3.5 Mylan N.V. Recent Development
11.4 Cadila Healthcare
11.4.1 Cadila Healthcare Company Details
11.4.2 Cadila Healthcare Business Overview
11.4.3 Cadila Healthcare Periodic Paralysis Treatment Introduction
11.4.4 Cadila Healthcare Revenue in Periodic Paralysis Treatment Business (2016-2021)
11.4.5 Cadila Healthcare Recent Development
11.5 Alembic Pharmaceuticals
11.5.1 Alembic Pharmaceuticals Company Details
11.5.2 Alembic Pharmaceuticals Business Overview
11.5.3 Alembic Pharmaceuticals Periodic Paralysis Treatment Introduction
11.5.4 Alembic Pharmaceuticals Revenue in Periodic Paralysis Treatment Business (2016-2021)
11.5.5 Alembic Pharmaceuticals Recent Development
11.6 Teva Pharmaceutical Industries Ltd
11.6.1 Teva Pharmaceutical Industries Ltd Company Details
11.6.2 Teva Pharmaceutical Industries Ltd Business Overview
11.6.3 Teva Pharmaceutical Industries Ltd Periodic Paralysis Treatment Introduction
11.6.4 Teva Pharmaceutical Industries Ltd Revenue in Periodic Paralysis Treatment Business (2016-2021)
11.6.5 Teva Pharmaceutical Industries Ltd Recent Development
11.7 X-GEN Pharmaceuticals, Inc
11.7.1 X-GEN Pharmaceuticals, Inc Company Details
11.7.2 X-GEN Pharmaceuticals, Inc Business Overview
11.7.3 X-GEN Pharmaceuticals, Inc Periodic Paralysis Treatment Introduction
11.7.4 X-GEN Pharmaceuticals, Inc Revenue in Periodic Paralysis Treatment Business (2016-2021)
11.7.5 X-GEN Pharmaceuticals, Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Periodic Paralysis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Beta-Blockers
Table 3. Key Players of Carbonic Anhydrase Inhibitor
Table 4. Key Players of Others
Table 5. Global Periodic Paralysis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Periodic Paralysis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Periodic Paralysis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Periodic Paralysis Treatment Market Share by Regions (2016-2021)
Table 9. Global Periodic Paralysis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Periodic Paralysis Treatment Market Share by Regions (2022-2027)
Table 11. Periodic Paralysis Treatment Market Trends
Table 12. Periodic Paralysis Treatment Market Drivers
Table 13. Periodic Paralysis Treatment Market Challenges
Table 14. Periodic Paralysis Treatment Market Restraints
Table 15. Global Periodic Paralysis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Periodic Paralysis Treatment Market Share by Players (2016-2021)
Table 17. Global Top Periodic Paralysis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Periodic Paralysis Treatment as of 2020)
Table 18. Ranking of Global Top Periodic Paralysis Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Periodic Paralysis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Periodic Paralysis Treatment Product Solution and Service
Table 22. Date of Enter into Periodic Paralysis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Periodic Paralysis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Periodic Paralysis Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Periodic Paralysis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Periodic Paralysis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Periodic Paralysis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Periodic Paralysis Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Periodic Paralysis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Periodic Paralysis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Periodic Paralysis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Periodic Paralysis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Periodic Paralysis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Periodic Paralysis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Periodic Paralysis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Periodic Paralysis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Periodic Paralysis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Periodic Paralysis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Periodic Paralysis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Periodic Paralysis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Periodic Paralysis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Periodic Paralysis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Periodic Paralysis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Periodic Paralysis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Periodic Paralysis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Periodic Paralysis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Periodic Paralysis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Periodic Paralysis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Periodic Paralysis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Periodic Paralysis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Periodic Paralysis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Periodic Paralysis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Periodic Paralysis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Periodic Paralysis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Periodic Paralysis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Periodic Paralysis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Periodic Paralysis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Periodic Paralysis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Periodic Paralysis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Periodic Paralysis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Strongbridge Biopharma Company Details
Table 63. Strongbridge Biopharma Business Overview
Table 64. Strongbridge Biopharma Periodic Paralysis Treatment Product
Table 65. Strongbridge Biopharma Revenue in Periodic Paralysis Treatment Business (2016-2021) & (US$ Million)
Table 66. Strongbridge Biopharma Recent Development
Table 67. Sun Pharmaceutical Industries Ltd Company Details
Table 68. Sun Pharmaceutical Industries Ltd Business Overview
Table 69. Sun Pharmaceutical Industries Ltd Periodic Paralysis Treatment Product
Table 70. Sun Pharmaceutical Industries Ltd Revenue in Periodic Paralysis Treatment Business (2016-2021) & (US$ Million)
Table 71. Sun Pharmaceutical Industries Ltd Recent Development
Table 72. Mylan N.V. Company Details
Table 73. Mylan N.V. Business Overview
Table 74. Mylan N.V. Periodic Paralysis Treatment Product
Table 75. Mylan N.V. Revenue in Periodic Paralysis Treatment Business (2016-2021) & (US$ Million)
Table 76. Mylan N.V. Recent Development
Table 77. Cadila Healthcare Company Details
Table 78. Cadila Healthcare Business Overview
Table 79. Cadila Healthcare Periodic Paralysis Treatment Product
Table 80. Cadila Healthcare Revenue in Periodic Paralysis Treatment Business (2016-2021) & (US$ Million)
Table 81. Cadila Healthcare Recent Development
Table 82. Alembic Pharmaceuticals Company Details
Table 83. Alembic Pharmaceuticals Business Overview
Table 84. Alembic Pharmaceuticals Periodic Paralysis Treatment Product
Table 85. Alembic Pharmaceuticals Revenue in Periodic Paralysis Treatment Business (2016-2021) & (US$ Million)
Table 86. Alembic Pharmaceuticals Recent Development
Table 87. Teva Pharmaceutical Industries Ltd Company Details
Table 88. Teva Pharmaceutical Industries Ltd Business Overview
Table 89. Teva Pharmaceutical Industries Ltd Periodic Paralysis Treatment Product
Table 90. Teva Pharmaceutical Industries Ltd Revenue in Periodic Paralysis Treatment Business (2016-2021) & (US$ Million)
Table 91. Teva Pharmaceutical Industries Ltd Recent Development
Table 92. X-GEN Pharmaceuticals, Inc Company Details
Table 93. X-GEN Pharmaceuticals, Inc Business Overview
Table 94. X-GEN Pharmaceuticals, Inc Periodic Paralysis Treatment Product
Table 95. X-GEN Pharmaceuticals, Inc Revenue in Periodic Paralysis Treatment Business (2016-2021) & (US$ Million)
Table 96. X-GEN Pharmaceuticals, Inc Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Periodic Paralysis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Beta-Blockers Features
Figure 3. Carbonic Anhydrase Inhibitor Features
Figure 4. Others Features
Figure 5. Global Periodic Paralysis Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hypokalemic Periodic Paralysis Case Studies
Figure 7. Hyperkalemic Periodic Paralysis Case Studies
Figure 8. Thyrotoxic Periodic Paralysis Case Studies
Figure 9. Others Case Studies
Figure 10. Periodic Paralysis Treatment Report Years Considered
Figure 11. Global Periodic Paralysis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Periodic Paralysis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Periodic Paralysis Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Periodic Paralysis Treatment Market Share by Regions (2022-2027)
Figure 15. Global Periodic Paralysis Treatment Market Share by Players in 2020
Figure 16. Global Top Periodic Paralysis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Periodic Paralysis Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Periodic Paralysis Treatment Revenue in 2020
Figure 18. Global Periodic Paralysis Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Periodic Paralysis Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Periodic Paralysis Treatment Market Share by Type (2016-2027)
Figure 22. North America Periodic Paralysis Treatment Market Share by Application (2016-2027)
Figure 23. North America Periodic Paralysis Treatment Market Share by Country (2016-2027)
Figure 24. United States Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Periodic Paralysis Treatment Market Share by Type (2016-2027)
Figure 28. Europe Periodic Paralysis Treatment Market Share by Application (2016-2027)
Figure 29. Europe Periodic Paralysis Treatment Market Share by Country (2016-2027)
Figure 30. Germany Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Periodic Paralysis Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Periodic Paralysis Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Periodic Paralysis Treatment Market Share by Region (2016-2027)
Figure 40. China Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Periodic Paralysis Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Periodic Paralysis Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Periodic Paralysis Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Periodic Paralysis Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Periodic Paralysis Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Periodic Paralysis Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Periodic Paralysis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Strongbridge Biopharma Revenue Growth Rate in Periodic Paralysis Treatment Business (2016-2021)
Figure 60. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Periodic Paralysis Treatment Business (2016-2021)
Figure 61. Mylan N.V. Revenue Growth Rate in Periodic Paralysis Treatment Business (2016-2021)
Figure 62. Cadila Healthcare Revenue Growth Rate in Periodic Paralysis Treatment Business (2016-2021)
Figure 63. Alembic Pharmaceuticals Revenue Growth Rate in Periodic Paralysis Treatment Business (2016-2021)
Figure 64. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Periodic Paralysis Treatment Business (2016-2021)
Figure 65. X-GEN Pharmaceuticals, Inc Revenue Growth Rate in Periodic Paralysis Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---